CogState Again Used in Successful Schizophrenia Study
Filed with ASX ·
Watch Cogstate's latest callCogstate (ASX:CGS) Q4 2026 Earnings Call · Replay · Aug 17Read the transcript of Cogstate (ASX:CGS) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from Cogstate
- CogState signs sales contract for phase 3 study
- CogState signs sales contract for phase 2 study
- CogState signs sales contract for large phase 2 study
- CogState Signs Contract For Phase 2 Schizophrenia Study
- CogState partners with Merck Canada
Later from Cogstate
- CogState 2010 AGM Address
- JV Agreement Signed
- Chairmans Address to Shareholders
- 2016 Financial Year Results
- Cogstate enters into agreement with Clinical Ink
Follow Cogstate into a list and get an email when it puts out news.
Follow Cogstate